Cluster immunotherapy with a glutaraldehyde-modified mixture of grasses results in an improvement in specific nasal provocation tests in less than 2.5 months of treatment

Clinical and Experimental Allergy

Volumn 38, Issue 6, 2008, Pages 987-994

  Subiza, J ^a   Feliu A ^a   Subiza, J L ^b   Uhlig, J ^c   Fernandez Caldas E ^d  

^a Centro de Asma y Alergia   (Spain)

^b Inmunotek   (Spain)

^c Roxall Medizin   (Germany)

^d Dr Beckmann Pharma   (Germany)

Author keywords

Allergens; Allergic rhinitis; Cluster immunotherapy; Dactylis; Nasal challenges; Trisetum

Indexed keywords

ALLERGEN; CLUSTOID; GLUTARALDEHYDE; GRASS POLLEN EXTRACT;

ADULT; ALLERGIC RHINITIS; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONCENTRATION (PARAMETERS); CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG SAFETY; FEMALE; GRASS POLLEN; HUMAN; IMMUNOTHERAPY; MALE; NOSE PROVOCATION TEST; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SENSITIZATION; SKIN TEST;

ADULT; ALLERGENS; ANALYSIS OF VARIANCE; DACTYLIS; DESENSITIZATION, IMMUNOLOGIC; DRUG ADMINISTRATION SCHEDULE; FEMALE; GLUTARAL; HUMANS; INHALATION EXPOSURE; INJECTIONS; MALE; NASAL PROVOCATION TESTS; POACEAE; POLLEN; RHINITIS, ALLERGIC, SEASONAL; SKIN TESTS; STATISTICS, NONPARAMETRIC; VACCINES;

EID: 44249114563     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/j.1365-2222.2008.02995.x     Document Type: Article

References (36)

1. Bousquet J, Lockey RF, Malling HJ, eds. WHO position paper. Allergen immunotherapy: therapeutic vaccines for allergic diseases. Allergy 1998 53 (Suppl) : 1 42.
2. Calderón MA, Alves B, Jacobson M, Hurwitz B, Sheikh A, Durham S. Allergen injection immunotherapy for seasonal allergic rhinitis. Cochrane Database Syst Rev 2007 Jan 24; (1):CD001936.
3. Norman PS, Lichtenstein LM, Marsh DG. Studies on allergoids from naturally occurring allergens. IV. Efficacy and safety of long-term allergoid treatment of ragweed hay fever. J Allergy Clin Immunol 1981 68 : 460 70.
4. Zenner HP, Baumgarten C, Rasp G et al. Short-term immunotherapy: a prospective, randomized, double-blind, placebo-controlled multicenter study of molecular standardized grass and rye allergens in patients with grass pollen-induced allergic rhinitis. J Allergy Clin Immunol 1997 100 : 23 9.
5. Klimek L, Mewes T, Wolf H, Hansen I, Schnitker J, Mann WJ. The effects of short-term immunotherapy using molecular standardized grass and rye allergens compared with symptomatic drug treatment on rhinoconjunctivitis symptoms, skin sensitivity, and specific nasal reactivity. Otolaryngol Head Neck Surg 2005 133 : 538 43.
6. Balda BR, Wolf H, Baumgarten C et al. Tree-pollen allergy is efficiently treated by short-term immunotherapy (STI) with seven preseasonal injections of molecular standardized allergens. Allergy 1998 53 : 740 8.
7. Casanovas M, Fernández-Caldas E, Alamar R, Basomba A. Comparative study of tolerance between unmodified and high doses of chemically modified allergen vaccines of Dermatophagoides pteronyssinus. Int Arch Allergy Immunol 2005 137 : 211 8.
8. Casanovas M, Sastre J, Fernández-Nieto M, Lluch M, Carnes J, Fernández-Caldas E. Double-blind study of tolerability and antibody production of unmodified and chemically modified allergen vaccines of Phleum pratense. Clin Exp Allergy 2005 35 : 1377 83.
9. Corrigan CJ, Kettner J, Doemer C, Cromwell O, Narkus A Study Group. Efficacy and safety of preseasonal-specific immunotherapy with an aluminium-adsorbed six-grass pollen allergoid. Allergy 2005 60 : 801 7.
10. Pastorello EA, Pravettoni V, Incorvaia C et al. Clinical and immunological effects of immunotherapy with alum-absorbed grass allergoid in grass-pollen-induced hay fever. Allergy 1992 47 (4 Pt 1) : 281 90.
11. Muhlethaler K, Wuthrich B, Peeters AG, Terki N, Girard JP, Frank E. Hyposensitization in pollinosis. Results of a 3-year controlled study with 2 depot-allergoid grass pollen extracts: aluminum hydroxide-adsorbed allergoid and tyrosine-adsorbed allergoid. Schweiz Rundsch Med Prax 1990 79 : 430 6.
12. Bousquet J, Hejjaoui A, Soussana M, Michel FB. Double-blind, placebo-controlled immunotherapy with mixed grass-pollen allergoids. IV. Comparison of the safety and efficacy of two dosages of a high-molecular-weight allergoid. J Allergy Clin Immunol 1990 85 : 490 7.
13. Bousquet J, Maasch HJ, Hejjaoui A et al. Double-blind, placebo-controlled immunotherapy with mixed grass-pollen allergoids. III. Efficacy and safety of unfractionated and high-molecular-weight preparations in rhinoconjunctivitis and asthma. J Allergy Clin Immunol 1989 84 (4 Pt 1) : 546 56.
14. Bousquet J, Maasch H, Martinot B, Hejjaoui A, Wahl R, Michel FB. Double-blind, placebo-controlled immunotherapy with mixed grass-pollen allergoids. II. Comparison between parameters assessing the efficacy of immunotherapy. J Allergy Clin Immunol 1988 82 (3 Pt 1) : 439 46.
15. Bousquet J, Frank E, Soussana M, Hejjaoui A, Maasch HJ, Michel FB. Double-blind, placebo-controlled immunotherapy with a high-molecular-weight, formalinized allergoid in grass pollen allergy. Int Arch Allergy Appl Immunol 1987 82 : 550 2.
16. Keskin O, Tuncer A, Adalioglu G, Sekerel BE, Sackesen C, Kalayci O. The effects of grass pollen allergoid immunotherapy on clinical and immunological parameters in children with allergic rhinitis. Pediatr Allergy Immunol 2006 17 : 396 407.
17. Drachenberg KJ, Proll S, Urban E, Woroniecki SR. Single-course specific immunotherapy with mixed pollen allergoids: results of a multi-centre study. Allergol Immunopathol (Madrid) 2003 31 : 77 82.
18. Kuhn W, Urbanek R, Forster J, Schreyer H, Wais U. Advantages of hyposensitization with a high dose of allergoid in pollen allergy. Klin Padiatr 1983 195 : 411 4.
19. Grammer LC, Shaughnessy MA, Suszko IM, Shauggnessy JJ, Patterson R. A double blind histamine placebo-controlled trial of polymerized whole grass for immunotherapy of grass allergy. J Allergy Clin Immunol 1983 72 : 448 53.
20. Grammer LC, Shaughnessy MA, Finkle SM, Shauggnessy JJ, Patterson R. A double-blind placebo-controlled trial of polymerized whole grass administered in an accelarated dosage schedule for immunotherapy of grass pollinosis. J Allergy Clin Immunol 1986 78 : 1180 4.
21. Subiza J, Jerez M, Jiménez JA et al. Allergenic pollen pollinosis in Madrid. J Allergy Clin Immunol 1995 96 : 15 23.
22. Cabrera M, Martínez-Cocera C, Fernández-Caldas E et al. Trisetum paniceum (wild oats) pollen counts and aeroallergens in the ambient air of Madrid, Spain. Int Arch Allergy Immunol 2002 128 : 123 9.
23. van Oort E, Dieker MC, de Heer PG, Peltre G, Aalberse RC, van Ree R. The major grass pollen group 5 allergen from Dactylis glomerata and its C-terminal split product both behave as dimers: implications for allergen standardization. Int Arch Allergy Immunol 2005 136 : 113 22. E-pub Jan 12, 2005.
24. Montero MT, Lopez C, Jimenez JA, Subiza J. Characterization of allergens from Trisetum paniceum pollen: an important aeroallergen in Mediterranean continental climatic areas. Clin Exp Allergy 1997 27 : 1442 8.
25. Dreborg S. Skin test use in Type I allergy testing. Position Paper. Allergy 1989 44 (S 10) : 1 59.
26. Boluda L, Sastre J, Casanovas M, Fernández Caldas E. Determination of Ole e 1 by enzyme immunoassay and scanning densitometry. Validation by skin-prick testing. J Immunol Methods 1999 223 : 17 26.
27. Council of Europe. European Pharmacopeia. Allergen Products (1997:1063), 3rd Edn. 1997.
28. Immunotherapy Subcommittee of EAACI. Position paper: Immunotherapy (EAACI) The European Academy of Allergology and Clinical Immunology. Allergy 1993 48 (14 Suppl 7 35.
29. Terrien MH, Rahm F, Fellrath JM, Spertini F. Comparison of the effects of terfenadine with fexofenadine on nasal provocation tests with allergen. J Allergy Clin Immunol 1999 103 : 1025 30.
30. Bousquet J, Van Cauwenberge P, Khaltaev N. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 2001 108 (5 Part 2) : S147 S334.
31. Adkinson NF Jr., Eggleston PA, Eney D et al. A controlled trial of immunotherapy for asthma in allergic children. N Engl J Med 1997 336 : 324 31.
32. Kim KW, Kim EA, Kwon BC et al. Comparison of allergic indices in monosensitized and polysensitized patients with childhood asthma. J Korean Med Sci 2006 21 : 1012 6.
33. Marogna M, Spadolini I, Massolo A et al. Effects of sublingual immunotherapy for multiple or single allergens in polysensitized patients. Ann Allergy Asthma Immunol 2007 98 : 274 80.
34. Creticos PS, Adkinson NF Jr., Kagey-Sobotka A et al. Nasal challenge with ragweed pollen in hay fever patients. Effect of immunotherapy. J Clin Invest 1985 76 : 2247 53. Erratum in: J Clin Invest 1986;78(5):1421.
35. Klimek L, Dormann D, Jarman ER, Cromwell O, Riechelmann H, Reske-Kunz AB. Short-term preseasonal birch pollen allergoid immunotherapy influences symptoms, specific nasal provocation and cytokine levels in nasal secretions, but not peripheral T-cell responses, in patients with allergic rhinitis. Clin Exp Allergy 1999 29 : 1326 1335.
36. Sastre J, Iraola V, Figueredo E, Tornero P, Fernandez-Caldas E. Mites in Madrid. Allergy 2002 57 : 58 9.